hello, everyone this is outnumbered, i am emily compagno here with my cohost, harris faulkner. joining us today is host of the kennedy save the world podcast, kennedy, fox & friends, carley shimkus, and former wisconsin congressmen and cohost of the bottom line on fox business, sean duffy. we began with president biden latest student loan handout. the white house is wiping out another $7.7 billion in student debt this morning, despite the supreme court ruling against the bailout last summit. just this year, president biden has canceled $1.2 billion in february, 5.8 billion in march, 7.4 billion in april, and another 6.1 billion earlier this month. in total, president has wiped out over $167 billion in student debt. remember, that is all on the taxpayers dime. you cannot wipe out that if someone has to absorb it somewhere else. but i would commander in chief is running to keep the bailout coming. saying i will never stop working to cancel student deck no matter how
A new analysis finds branded insulin glargine (Lantus) still has a majority of total market volume and new drug starts despite competition from Semglee, an interchangeable biosimilar.
Biosimilars are starting to make a significant impact in overall drug spending, which is what they are designed to do, said Scott Soefje, PharmD, director of pharmacy cancer care at Mayo Clinic.
CANONSBURG (dpa-AFX) - Mylan Pharmaceuticals Inc., affiliated to healthcare company Viatris Inc., is recalling one batch of its non-interchangeable Semglee (insulin glargine injection), 100 units/ml